✦ LIBER ✦

Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma

✍ Scribed by J.E. Brown*; C.H. Barrios; I.J. Diel; T. Facon; K. Fizazi; T. Ibrahim; F. Saad; F. Senecal; S.M. Stemmer; A. Stopeck; S. Takahashi; C. Van Poznak; L. Zhou; P. Carriere; A. Daniels; R. Dansey

Book ID: 116323973
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 71 KB
Volume: 48
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2010.10.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results From a Phase 3 Randomized, Doubl

Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

✍ Roger von Moos; David Henry; Saroj Vadhan-Raj; Vania Hungria; Andrew Spencer; Ve 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Denosumab versus zoledronic acid (ZA) fo

Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials

✍ A. Lipton*; A. Stopeck; R. von Moos; D. Henry; G. Richardson; G. Rodriguez; H. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB